Joint Programme - Neurodegenerative Disease
Transnational research proposals 2013
”European research projects for the identification of
genetic, epigenetic and environmental risk and protective
factors for Neurodegenerative Diseases”
Proposal Application Form
I. General information
Acronym (10 characters max.):
Project Title:
Project Coordinator:
NameInstitution/Department
Address
Country
Phone + Fax
Total funding applied for: €
Please note
- Italic text contains further information and should be deleted when the final proposal is generated.
- Please also regard information provided in the “call text” document published at the JPND website () and by the national funding organisations.
- Some funding agencies have budget limitations.We strongly recommend consulting the respective national contact person.
- No annex is allowed in addition to this template. If any annex is attached, it will not be considered.
- Electronic proposal submission is mandatory (). The electronic submission system will close at 23:59h C. E. T. on March – 19, 2013. Proposals that do not meet the deadline will be rejected.
- It is absolutely mandatory to meet the format of the proposal template (DIN-A4, Arial, minimum font size 10 pt (except references), page limit as outlined below). A formal check of all proposals will be conducted right after closure of the electronic submission gate. Proposals not meeting the formal criteria willbe rejected without further review.
JPND funded Partners:
No. / Country / Name of the group leader / Institution and full affiliations(e.g. address, phone + fax, email)
2
3
4
Please insert further lines to add more partners, as appropriate
Please note that each proposal must involve a minimum of three and a maximum of ten (3-10) JPND funded partners. Each consortium must involve JPND funded partners from at least three different countries.
Other partners can join the consortium if they can secure their own funding and as long as the majority of research groups and the coordinator are from JPND participating countries. If this is relevant for your consortium, please list non-funded partners below and explain collaboration in chapters 3 and 4.
JPND Non-funded Partners:
No. / Country / Name of the group leader / Institution and full affiliations(e.g. address, phone + fax, email)
Please insert further lines to add more partners, as appropriate
II. Abstracts
- Scientific abstract of the project (max. 1/2 page)
Please provide a short summary of the projects aims and the workplan.
Brief assessment of the projects relevance for the aims of the call(max. 1/2 page)
Please provide your own assessment of the relevance of the project with regard to a) the aims of the call, b) the innovation potential of the project, c) the impact of the expected results for the scientific community and the field of research
Key words (max. 10)
Please provide a list of keywords in matter of your project
III. Detailed information
1. Backgroundand present state of the art in the research field, rationale and preliminary results(max. 2 pages)
2. Work plan highlighting the originality andnovelty (max. 15 pages, including references and figures)
Including aims, a clear statement of the research questions,methodology,time plan, project coordination and management, availability and accessibility of well-characterized patient groups/data/samples/resources/infrastructures. References and figures have to be included in the 15 pages; however, references may be included in smaller font size. Inclusion of a pert chart(explaining the work packages and the role of the partners) is recommended.
3. Structure and added value of the proposed collaboration (max. 1 page)
Structure of the consortium and involvement of non-JPND funded participants in the consortium.Appropriateness of the team in terms of research area, research methods, complementarity of expertise and synergistic potential. Level of training/knowledge exchange between research organisations. Please also explain the added value of a transnational approach.
4. Possible exploitation of expected project results (max. 1 page)
Please explain the impact of the expected results, including potential for future clinical and health related applications. List the project deliverables. Demonstrate the potential for collaboration with key organisations responsible for implementing or applying the findings. Describe any plans for partnership working, collaboration, and dissemination and knowledge exchange plans aimed at ensuring optimal uptake and application of the study findings. Please also explain how data management will be performed and what the data/material sharing policy is.
5. Ethical and Legal issues (max. 1 page)
These include, but are not limited to,informed consent, data protection, use of animalsand legal issues(e.g., handling of intellectual property rights (IPR), patenting…), according to national regulations.
6. Brief CVs (max. 1 page each)
For each group leader with a list of up to five relevant publications within the last five years, demonstrating the competence to carry out the project, description of patents and ongoing projects of each participating group relevant for the present topic, indicating funding sources and possible overlaps with proposal
7. Justification of requested budget (max. 3 pages)
For each funded cooperation partner, please explain shortly the following budget items (if applied for):
Personnel:Person-Months and position of employment (e.g. 18 Person Months ofResearch assistant)
Consumables:List of consumables (keywords, e.g., antibodies, chemicals, cell culture medium…)
Equipment:Please provide further information(e.g. Real-time PCR cycler) and a short justification (e.g., why is the cycler needed?).
Other direct costs:Please explain the budget requested here, including justification
In addition, specification of co-funding from other sources necessary for the project as well as secured funding of non-JPND funded partners of the consortium should be explained here, if applicable.
8. Budget plan
Please use provided form at the end of this template. In this form, you only need to insert the amount of requested funding, without any justification. Please make sure that budget items are realistically planned and explained in chapter 7.
1
JPND call 2013: risk and protective factorsBudget plan of the project(in €)
Acronym:
Coordinator:
Last Name (group leader) / Country / Funding org.1 / Personnel / Consumables / Equipment / Travel / Other direct costs2 / Overheads3 / Total budget request to the funding agency
Project coordinator
Partner 2
Partner 3
Partner 4
Please insert further lines to add more partners,as appropriate
TotalTotal
1abbreviation of funding organisation
2e.g. subcontracting, provisions, licensing fees; may not be eligible costs in all countries (will be handled according to national regulations)
3overhead costs: funding according to national regulations. The total budget should show the final costs to the funding agency after country-specific regulations have been applied. An additional column can be inserted if needed, to show 100% costs.
We strongly recommend applicants to consultthe national contact person.
Please note that funding decision is based on the information in this template.
1